A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease | MicrobiomeTrials← Back to trialsNCT06587828
A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease
RecruitingOBSERVATIONAL
Trial Details
Start: 2023-01-03Est. Completion: 2027-01
Enrollment target: 300 participants Locations- Knowledge Research Center, Orange, California, United States
- Cura Clinical Research, Sherman Oaks, California, United States
- Arnold Arthritis & Rheumatology, Skokie, Illinois, United States
- University of Kentucky Research Foundation, Lexington, Kentucky, United States
- Massachusetts Eye Research and Surgery Institution (MERSI), Waltham, Massachusetts, United States
- Susquehanna Research Group, Harrisburg, Pennsylvania, United States
- Nexus Research, Cranston, Rhode Island, United States
- Nexus Research, Cranston, Rhode Island, United States
- RI Rheumatology, Cranston, Rhode Island, United States
- Palmetto Gastroenterology Clinical Research, LLC, Summerville, South Carolina, United States
- Novel Research, Bellaire, Texas, United States
- Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Other microbiome trials you might be interested in
Type 1 Diabetes (T1D)
Islet transplantation restores glucose tolerance in people living with diabetes characterised by high glycaemic variabil…
Strasbourg, FranceEst. completion Jan 2032
Systemic SclerosisScleroderma
The purpose of this study is to evaluate the efficacy and safety of treatment with subcutaneous anifrolumab versus place…
Scottsdale, United StatesEst. completion Jan 6, 2027
Recruiting
Lymphohistiocytosis, HemophagocyticSecondary Hemophagocytic LymphohistiocytosisMacrophage Activation SyndromeHyperinflammatory Syndromes
Background:
Hemophagocytic lymphohistiocytosis (HLH) is a disease caused by disrupted immune function. People with HLH …
Bethesda, United StatesEst. completion Oct 1, 2030